2Inc. and Meridian America Medicals, Inc. (collectively,“Meridian”) manufacture and market laser devices for medicaluse. Erchonia and Meridian have used the term “lipolaser” inconnection with their respective low-level lasers designed forliposuction procedures. Erchonia has sued Meridian fortrademark infringement and false advertising, and Meridian hasmoved for summary judgment. For the reasons stated below,Meridian’s motion is granted.BACKGROUNDThe undisputed facts of record, or, where disputed, takenin the light most favorable to Erchonia, establish thefollowing. In 2001, Erchonia developed its lipolaser,
1
a medicallaser that applies low-level light to the skin’s surface as partof a process to remove cellular fat content. The lipolaser isused before liposuction to liquefy the fat.
2
According toErchonia’s expert, Dr. William B. Locander, the term “lipolaser”suggests a “fat laser machine,”
and is an approximate literaltranslation of “fat laser.”
1
When this Opinion refers to the parties’ lipolasers, it usesthe term not in a trademark sense, but to describe certainproducts.
2
The lipolaser is also used for lipoplasty. Liposuction andlipoplasty refer to essentially the same procedures and are usedinterchangeably in this Opinion.
Case 1:07-cv-08696-DLC Document 74 Filed 06/01/2009 Page 2 of 24
Leave a Comment